Form 4 for CRVL CORVEL CORP
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-08 · accession 0001754499-21-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-10 | 2021-11-08 | CRVL | O'Brien Brandon | CFO | M - OptEx | $58.56 | +1,000 | 2,698 | +59% | +$58.6K |
| DM | 2021-11-10 | 2021-11-08 | CRVL | O'Brien Brandon | CFO | S - Sale+OE | $189.50 | -1,000 | 2,656 | -27% | -$189.5K |
| DM | 2021-11-10 | 2021-11-08 | CRVL | O'Brien Brandon | CFO | M - OptEx | $0.00 | -1,000 | 3,333 | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-08 | M | A | 331 | $59.32 | 2,987 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-08 | S | D | 331 | $189.50 | 2,656 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-08 | M | A | 510 | $59.32 | 3,166 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-08 | S | D | 42 | $189.50 | 2,656 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-08 | M | A | 105 | $57.35 | 2,761 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-08 | S | D | 510 | $189.50 | 2,656 | D | — | — | |
| 7 | Common | Common Stock | 2021-11-08 | M | A | 12 | $48.35 | 2,668 | D | — | — | |
| 8 | Common | Common Stock | 2021-11-08 | S | D | 12 | $189.50 | 2,656 | D | — | — | |
| 9 | Common | Common Stock | 2021-11-08 | M | A | 42 | $49.40 | 2,698 | D | — | — | |
| 10 | Common | Common Stock | 2021-11-08 | S | D | 105 | $189.50 | 2,656 | D | — | — | |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-08 | M | D | 331 | $0.00 | 3,843 | D | $59.32 · — to 2023-11-01 | 331 Common Stock | (F2) Option will vest based on achievement of certain performance criteria relating to earnings growth. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-08 | M | D | 105 | $0.00 | 187 | D | $57.35 · — to 2023-08-02 | 105 Common Stock | (F1) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-08 | M | D | 42 | $0.00 | 50 | D | $49.40 · — to 2023-05-03 | 42 Common Stock | (F1) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-08 | M | D | 12 | $0.00 | 0 | D | $48.35 · — to 2022-08-03 | 12 Common Stock | (F1) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-08 | M | D | 510 | $0.00 | 3,333 | D | $59.32 · — to 2023-11-01 | 510 Common Stock | (F2) Option will vest based on achievement of certain performance criteria relating to earnings growth. |